Literature DB >> 8375929

Association of insulin-like growth-factor-I-induced DNA synthesis with phosphorylation and nuclear exclusion of p53 in human breast cancer MCF-7 cells.

K Takahashi1, K Suzuki.   

Abstract

Human breast cancer MCF-7 cells, growth-arrested by serum starvation, were stimulated with recombinant human insulin-like growth factor-I (IGF-I). An increase in DNA synthesis was induced 20 hr later, which was as effective as that induced by serum. The increase in DNA synthesis was significantly inhibited either by antibody to the IGF-I receptor or by the tyrosine kinase inhibitor, methyl-2,5-dihydroxycinnamate (2,5-MeC). The IGF-I-induced DNA synthesis coincided with an elevated level of phosphorylation of p53 on tyrosine and an alteration in the subcellular distribution of the protein from the nucleus to the cytoplasm. Whereas the increases in DNA synthesis and p53 phosphorylation were inhibited by antibody to the IGF-I receptor and by 2,5-Mec, the nuclear exclusion of p53 was prevented by the antibody and also, although not significantly, by 2,5-Mec. The results suggest that growth stimulation of MCF-7 cells by IGF-I is accompanied by tyrosine phosphorylation and nuclear exclusion of p53.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8375929     DOI: 10.1002/ijc.2910550322

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  14 in total

Review 1.  Cell cycle checkpoints as therapeutic targets.

Authors:  Z A Stewart; J A Pietenpol
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-10       Impact factor: 2.673

2.  L-methionine-induced alterations in molecular signatures in MCF-7 and LNCaP cancer cells.

Authors:  Maximo A Benavides; Dong Hu; Marie Kristine Baraoidan; Annette Bruno; Pan Du; Simon Lin; Wancai Yang; Kirby I Bland; William E Grizzle; Maarten C Bosland
Journal:  J Cancer Res Clin Oncol       Date:  2010-05-09       Impact factor: 4.553

3.  The beta subunit of voltage-gated Ca2+ channels interacts with and regulates the activity of a novel isoform of Pax6.

Authors:  Yun Zhang; Yoichi Yamada; Mingming Fan; Saroja D Bangaru; Bochao Lin; Jian Yang
Journal:  J Biol Chem       Date:  2009-11-16       Impact factor: 5.157

4.  Effects of febrile temperature on adenoviral infection and replication: implications for viral therapy of cancer.

Authors:  Stephen H Thorne; Gabriel Brooks; Yeun-Ling Lee; Tina Au; Lawrence F Eng; Tony Reid
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

5.  Tyrosine kinase-dependent release of an adenovirus preterminal protein complex from the nuclear matrix.

Authors:  P C Angeletti; J A Engler
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

6.  Evaluation of cytotoxic activities of snake venoms toward breast (MCF-7) and skin cancer (A-375) cell lines.

Authors:  Michael J Bradshaw; Anthony J Saviola; Elizabeth Fesler; Stephen P Mackessy
Journal:  Cytotechnology       Date:  2014-11-19       Impact factor: 2.058

7.  Wild-type p53 gene-induced morphological changes and growth suppression in hepatoma cells.

Authors:  S Terai; T Noma; T Kimura; A Nakazawa; F Kurokawa; K Okita
Journal:  J Gastroenterol       Date:  1997-06       Impact factor: 7.527

8.  Suppression by L-methionine of cell cycle progression in LNCaP and MCF-7 cells but not benign cells.

Authors:  Maximo A Benavides; Karen L Hagen; Wenfeng Fang; Pan Du; Simon Lin; Mary P Moyer; Wancai Yang; Kirby I Bland; William E Grizzle; Maarten C Bosland
Journal:  Anticancer Res       Date:  2010-06       Impact factor: 2.480

Review 9.  Energy balance, host-related factors, and cancer progression.

Authors:  Stephen D Hursting; Nathan A Berger
Journal:  J Clin Oncol       Date:  2010-08-09       Impact factor: 44.544

10.  Enhanced expression of an insulin growth factor-like binding protein (mac25) in senescent human mammary epithelial cells and induced expression with retinoic acid.

Authors:  K Swisshelm; K Ryan; K Tsuchiya; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.